Evaluation of the Pharmacokinetics, Disposition, and Metabolism of Miricorilant, a Novel Glucocorticoid Receptor Modulator for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in Nonclinical and Clinical Studies.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.70113
Abstract: Abstract Miricorilant is a novel selective glucocorticoid receptor (GR) modulator with mixed agonist/antagonist effects at the GR and modest antagonism at the mineralocorticoid receptor that is being developed for the treatment of metabolic dysfunctionâassociated steatohepatitis.… read more here.
Keywords: glucocorticoid receptor; receptor; miricorilant; treatment metabolic ... See more keywords